yinglunz (@yinglun122)
派早报：Apple 确认将于三月发布多款新品等
。业内人士推荐同城约会作为进阶阅读
但这种垄断格局，即将被打破，多款在研新药正从作用机制到给药方式，向Vosoritide发起挑战。Ascendis的TransCon-CNP通过包裹技术延长了药物作用时间，实现了周剂给药，目前正处于FDA审批阶段；而BridgeBio的口服药Infigratinib，则从作用机制到用药体验实现全面突破。
《克里斯托弗一家》定档 4 月
The pre-solicitation released this week is not a request for proposals from industry—it states that a draft Request for Proposals is forthcoming. Rather, it seeks feedback from industry and interested stakeholders about an "objectives and requirements" document that outlines the goals of the Mars mission.